About Us

Leading Innovation in Stem Cell Research

Our laboratory proudly aligns with the National Marrow Donor Program (NMDP) and participates in the Be the Match® Registry, contributing to public cord blood transplantation initiatives that save lives.

We have achieved a significant milestone by receiving FDA authorization for an Investigational New Drug (IND) Application. This approval allows us to conduct a Phase 1 study on our allogeneic donor umbilical cord blood-derived stem cell product, specifically targeting lower back pain associated with the Sacroiliac Joint (SIJ).

Our state-of-the-art manufacturing facilities operate within certified ISO 7 and ISO 6 clean room spaces. Here, we adhere strictly to cGMP/GTP guidelines and employ aseptic techniques to ensure the highest quality and safety of our products.

Ethical Sourcing

Our Commitment

The umbilical cords we use are ethically sourced, underpinning our commitment to responsible and sustainable scientific advancement. We maintain the highest standards of cord blood banking, as evidenced by our affiliations and compliance with renowned organizations:

Our laboratory is fully licensed in every state that requires licensure for operation. Furthermore, we are authorized to conduct collections across all 50 US states, showcasing our wide-reaching capability to support research and therapeutic developments.

Through our dedication to excellence, innovation, and ethical practices, we strive to advance medical science and improve patient outcomes across the globe.

Navigation
HomeOur ProductFAQ’sBlogContact Us
Company
About UsContact UsPrivacy PolicyPhysician Login
© 2024 - Americell | All rights reserved | Terms & Conditions

The information contained on this website is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any medical conditions or diseases. Americell does not make any claims regarding the curative properties of the umbilical cord blood derived stem cells products distributed by us. While no adverse effects or critical side-effects have been reported to date, the possibility of such occurrences cannot be entirely ruled out. Our umbilical cord blood derived stem cells products are exclusively distributed to healthcare professionals who are fully informed and knowledgeable about the regulated use of stem cell therapies. The stem cells are procured and processed in an FDA-approved laboratory following stringent compliance standards and rigorous quality control measures to ensure the quality and purity of these minimally manipulated cells. It's essential to note that the use of stem cell products and therapies should be conducted under the strict guidance and supervision of qualified healthcare professionals. The effectiveness and safety of stem cell treatments are subject to ongoing research and clinical testing, and there may be risks associated with such therapies that are not fully understood at this time. The information provided on this website should not be used as a substitute for professional medical advice, diagnosis, or treatment. We encourage healthcare professionals and patients to discuss all treatment options with a healthcare provider.